MeSH term
Frequency | Condition_Probility | DNA-Binding Proteins/chemistry/*metabolism | 2 | 1.0 |
Humans | 69 | 0.0 |
Research Support, Non-U.S. Gov't | 51 | 0.0 |
Adult | 8 | 0.0 |
Aged | 4 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Case-Control Studies | 4 | 0.0 |
Comparative Study | 8 | 0.0 |
DNA Repair/genetics | 4 | 2.0 |
DNA-Binding Proteins/*genetics/metabolism | 2 | 0.0 |
*Drosophila Proteins | 3 | 0.0 |
*Endonucleases | 4 | 4.0 |
Female | 15 | 0.0 |
Gene Expression | 5 | 0.0 |
Genetic Predisposition to Disease | 4 | 0.0 |
Male | 12 | 0.0 |
Middle Aged | 7 | 0.0 |
Pilot Projects | 2 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 34 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Risk Factors | 3 | 0.0 |
*DNA Damage | 7 | 1.0 |
*DNA Helicases | 3 | 1.0 |
*DNA Repair | 31 | 4.0 |
DNA-Binding Proteins/*genetics | 12 | 0.0 |
Exons | 2 | 0.0 |
Genotype | 7 | 0.0 |
Homozygote | 3 | 0.0 |
Neoplasms/genetics | 4 | 3.0 |
*Polymorphism, Genetic | 5 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
*Transcription Factors | 3 | 0.0 |
*Ultraviolet Rays | 7 | 3.0 |
Base Sequence | 14 | 0.0 |
Cell Line | 12 | 0.0 |
DNA Primers | 5 | 0.0 |
Ultraviolet Rays | 13 | 2.0 |
Child | 4 | 0.0 |
DNA Repair/*genetics | 14 | 4.0 |
DNA, Neoplasm/analysis | 2 | 0.0 |
DNA-Binding Proteins/genetics | 8 | 0.0 |
*Loss of Heterozygosity | 2 | 0.0 |
Microsatellite Repeats | 3 | 0.0 |
Xeroderma Pigmentosum/genetics | 4 | 13.0 |
Cell Survival/genetics/radiation effects | 2 | 15.0 |
Cells, Cultured | 10 | 0.0 |
*Chromosomes, Human, Pair 3 | 3 | 0.0 |
Pedigree | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 4 | 0.0 |
Skin Neoplasms/genetics | 2 | 6.0 |
Ultraviolet Rays/adverse effects | 4 | 6.0 |
Severity of Illness Index | 2 | 0.0 |
Time Factors | 5 | 0.0 |
Mutation | 9 | 0.0 |
Animals | 30 | 0.0 |
DNA Repair | 6 | 0.0 |
Genes, p53 | 2 | 0.0 |
*Genetic Predisposition to Disease | 3 | 0.0 |
Mice | 11 | 0.0 |
Neoplasms/*genetics | 2 | 0.0 |
Cell-Free System | 2 | 0.0 |
DNA Damage | 9 | 1.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 4 | 0.0 |
Heat | 2 | 0.0 |
Hela Cells | 13 | 0.0 |
Precipitin Tests | 2 | 0.0 |
Protein Binding | 5 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 2 | 0.0 |
*Transcription Factors, TFII | 5 | 4.0 |
Transfection | 5 | 0.0 |
Proteins/genetics | 4 | 0.0 |
DNA-Binding Proteins/*metabolism | 4 | 0.0 |
Kinetics | 4 | 0.0 |
Macromolecular Substances | 4 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Transcription, Genetic | 7 | 0.0 |
Heterozygote | 2 | 0.0 |
Mice, Mutant Strains | 3 | 0.0 |
Ultraviolet Rays/*adverse effects | 2 | 4.0 |
Protein p53/*genetics | 2 | 1.0 |
DNA-Binding Proteins/genetics/*physiology | 2 | 0.0 |
Xeroderma Pigmentosum/*genetics | 7 | 12.0 |
*Genes, p53 | 3 | 0.0 |
Mice, Knockout | 4 | 0.0 |
Skin Neoplasms/*genetics/pathology | 2 | 3.0 |
Binding Sites | 3 | 0.0 |
Cisplatin/*pharmacology | 2 | 1.0 |
Molecular Weight | 2 | 0.0 |
Nucleic Acid Conformation | 3 | 0.0 |
Chromosome Mapping | 4 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Molecular Sequence Data | 16 | 0.0 |
Transcription Factors/metabolism | 2 | 0.0 |
Blotting, Northern | 3 | 0.0 |
Amino Acid Sequence | 8 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Tumor Cells, Cultured | 4 | 0.0 |
Child, Preschool | 2 | 0.0 |
Genetic Markers/genetics | 2 | 0.0 |
Survival Rate | 2 | 0.0 |
DNA Repair/*physiology | 3 | 2.0 |
Dose-Response Relationship, Radiation | 3 | 0.0 |
DNA/metabolism | 3 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
*DNA-Binding Proteins | 3 | 0.0 |
Fibroblasts | 2 | 0.0 |
Genetic Complementation Test | 2 | 0.0 |
Binding Sites/genetics | 2 | 0.0 |
DNA-Binding Proteins/*chemistry/genetics/*metabolism | 2 | 3.0 |
In Vitro | 2 | 0.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
Recombinant Proteins/chemistry/genetics/metabolism | 2 | 0.0 |
Sequence Deletion | 2 | 0.0 |
Xeroderma Pigmentosum/genetics/*metabolism | 2 | 50.0 |
Gene Expression Profiling | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Xeroderma Pigmentosum | 2 | 13.0 |
Polymerase Chain Reaction | 3 | 0.0 |
DNA-Binding Proteins/metabolism | 3 | 0.0 |
Hamsters | 7 | 0.0 |
Proteins/*metabolism | 2 | 0.0 |
Gene Expression Regulation | 4 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Spodoptera | 2 | 0.0 |
Blotting, Western | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
CHO Cells | 5 | 0.0 |
DNA Helicases/genetics | 2 | 9.0 |
Gene Frequency | 2 | 0.0 |
*Mutation | 2 | 0.0 |
Plasmids | 2 | 0.0 |
Genes, Fungal | 2 | 1.0 |
Restriction Mapping | 2 | 0.0 |
Saccharomyces cerevisiae/*genetics | 2 | 1.0 |
Pyrimidine Dimers/metabolism | 2 | 11.0 |
*Schizosaccharomyces pombe Proteins | 2 | 2.0 |
*Transglutaminases | 2 | 33.0 |
Biological Markers | 2 | 0.0 |
Protein p53/*metabolism | 2 | 0.0 |
Skin/cytology | 2 | 1.0 |
Nuclear Proteins/genetics | 2 | 0.0 |
Adolescent | 2 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Cell Survival/radiation effects | 2 | 2.0 |
DNA-Binding Proteins/genetics/*metabolism | 2 | 0.0 |
Fibroblasts/metabolism/radiation effects | 2 | 10.0 |